Biblio
“Reproducibility of Alzheimer's Disease Cerebrospinal Fluid-Biomarker Measurements under Clinical Routine Conditions.”, J Alzheimers Dis, vol. 62, no. 1, pp. 203-212, 2018.
, “Reaction of Amyloid-β Peptide Antibody with Different Infectious Agents Involved in Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 2, pp. 847-860, 2018.
, “Effect of Lecanemab in Early Alzheimer's Disease: Mechanistic Interpretation in the Amyloid Cascade Hypothesis 2.0 Perspective.”, J Alzheimers Dis, vol. 93, no. 4, pp. 1277-1284, 2023.
, “Synthetic Fragment of Receptor for Advanced Glycation End Products Prevents Memory Loss and Protects Brain Neurons in Olfactory Bulbectomized Mice.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1061-1076, 2018.
, “Education Moderates the Relation Between APOE ɛ4 and Memory in Nondemented Non-Hispanic Black Older Adults.”, J Alzheimers Dis, vol. 72, no. 2, pp. 495-506, 2019.
, “Modifiable Risk Factors for Prevention of Dementia in Midlife, Late Life and the Oldest-Old: Validation of the LIBRA Index.”, J Alzheimers Dis, vol. 58, no. 2, pp. 537-547, 2017.
, “Preclinical Alzheimer's Disease: Implications for Refinement of the Concept.”, J Alzheimers Dis, vol. 64, no. s1, pp. S213-S227, 2018.
, “Progression from Prodromal Alzheimer's Disease to Mild Alzheimer's Disease Dementia in the Verubecestat APECS Study: Adjudicating Diagnostic Transitions.”, J Alzheimers Dis, vol. 92, no. 1, pp. 341-348, 2023.
, “Blood Protein Markers of Neocortical Amyloid-β Burden: A Candidate Study Using SOMAscan Technology.”, J Alzheimers Dis, 2015.
, “A Pathway Based Classification Method for Analyzing Gene Expression for Alzheimer's Disease Diagnosis.”, J Alzheimers Dis, vol. 49, no. 3, pp. 659-69, 2016.
, “Genetic Risk as a Marker of Amyloid-β and Tau Burden in Cerebrospinal Fluid.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1417-1427, 2017.
, “Effect of Education on Alzheimer's Disease-Related Neuroimaging Biomarkers in Healthy Controls, and Participants with Mild Cognitive Impairment and Alzheimer's Disease: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 63, no. 2, pp. 861-869, 2018.
, “Waist Circumference and Domain-Specific Cognitive Function Among Non-Demented Japanese Older Adults Stratified by Sex: Results from the Takashima Cognition Study.”, J Alzheimers Dis, vol. 73, no. 3, pp. 887-896, 2020.
, “Amyloid Deposition Is Greater in Cerebral Gyri than in Cerebral Sulci with Worsening Clinical Diagnosis Across the Alzheimer's Disease Spectrum.”, J Alzheimers Dis, vol. 83, no. 1, pp. 423-433, 2021.
, “Longitudinal Characterization of [18F]-FDG and [18F]-AV45 Uptake in the Double Transgenic TASTPM Mouse Model.”, J Alzheimers Dis, vol. 55, no. 4, pp. 1537-1548, 2017.
, “The Association of Mid- and Late-Life Systemic Inflammation with Brain Amyloid Deposition: The ARIC-PET Study.”, J Alzheimers Dis, vol. 66, no. 3, pp. 1041-1052, 2018.
, “The Spectrum of Alzheimer-Type Pathology in Cognitively Normal Individuals.”, J Alzheimers Dis, vol. 91, no. 2, pp. 683-695, 2022.
, “Cognitive and Neuropsychological Profiles in Alzheimer's Disease and Primary Age-Related Tauopathy and the Influence of Comorbid Neuropathologies.”, J Alzheimers Dis, vol. 92, no. 3, pp. 1037-1049, 2023.
, “Deaths with Dementia in Indigenous and Non-Indigenous Australians: A Nationwide Study.”, J Alzheimers Dis, vol. 81, no. 4, pp. 1589-1599, 2021.
, “Update on Vascular Cognitive Impairment Associated with Subcortical Small-Vessel Disease.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1417-1441, 2018.
, “Association between Plasma Levels of PAI-1, tPA/PAI-1 Molar Ratio, and Mild Cognitive Impairment in Chinese Patients with Type 2 Diabetes Mellitus.”, J Alzheimers Dis, vol. 63, no. 2, pp. 835-845, 2018.
, “Characterizing Gut Microbiota in Older Chinese Adults with Cognitive Impairment: A Cross-Sectional Study.”, J Alzheimers Dis, vol. 101, no. 3, pp. 761-771, 2024.
, “The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1.”, J Alzheimers Dis, vol. 64, no. 1, pp. 149-169, 2018.
, “Peptidylarginine Deiminase and Alzheimer's Disease.”, J Alzheimers Dis, vol. 85, no. 2, pp. 473-484, 2022.
, “S1PR2 Regulates Autophagy Through the AKT/mTOR Pathway to Promote Pathological Damage in Alzheimer's Disease.”, J Alzheimers Dis, vol. 96, no. 4, pp. 1489-1504, 2023.
,